Physician profile
Edwin Theosmy
NPI 1720435605
$4,728.72
in general payments reported to CMS, 2019-2025
13 companies · $472 in 2025
The $472 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.57 · 2022: $2,250 · 2023: $1,800 · 2024: $191 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,554 · Food and Beverage: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,554.42 |
| Food and Beverage | $908.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,931.75 | 2022-2025 | Mako, Triathlon, Insignia |
| Orthalign INC | $168.83 | 2022 | |
| Depuy Synthes Sales INC. | $124.26 | 2022 | |
| Medical Device Business Services, INC. | $115.13 | 2022 | |
| Smith+Nephew, INC. | $79.47 | 2022-2025 | Pico 14 |
| Linkbio Corp | $63.09 | 2025 | |
| Medacta USA, INC. | $59.00 | 2023 | Gmk Sphere |
| Bioventus LLC | $53.52 | 2024 | Durolane |
| Davol INC. | $46.98 | 2024 | Arista Ah Flexitip |
| Zimmer Biomet Holdings, INC. | $40.00 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.09 | 2024 | Iovera, Exparel, Zilretta |
| Liberty Surgical INC. | $15.57 | 2019 | |
| Seapearl East, INC | $14.03 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Theosmy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.